CYCS Monoclonal Antibody

說明書

中文名稱：

CYCS鼠單克隆抗體
貨號：

CSB-MA080196
規(guī)格：

￥1090
圖片：
Immunohistochemical analysis of paraffin-embedded human Breast caricnoma using CYCS Monoclonal Antibody.

Western blot analysis of 1) Hela, 2) 293T, 3) 3T3, 4) Mouse Liver Tissue, 5) Rat Liver Tissue, 6) Rat Kidney Tissue using CYCS Monoclonal Antibody.
其他：

產(chǎn)品詳情
產(chǎn)品評價(jià)
相關(guān)產(chǎn)品
靶點(diǎn)詳情

產(chǎn)品詳情

產(chǎn)品描述：

CYCS Monoclonal Antibody（CUSABIO貨號：CSB-MA080196）是一款高特異性重組抗體，靶向細(xì)胞色素C（CYCS）——線粒體電子傳遞鏈的核心組分，同時(shí)作為細(xì)胞凋亡信號轉(zhuǎn)導(dǎo)的關(guān)鍵介質(zhì)，其表達(dá)水平與能量代謝調(diào)控、程序性細(xì)胞死亡等生物學(xué)過程密切相關(guān)，在腫瘤發(fā)生、神經(jīng)退行性疾病等研究領(lǐng)域具有重要價(jià)值。該抗體經(jīng)ELISA、Western Blot及免疫組化（IHC）三大平臺(tái)嚴(yán)格驗(yàn)證，可穩(wěn)定識(shí)別人類、小鼠及大鼠種屬來源的CYCS蛋白，其明確的條帶特異性與清晰的免疫染色效果為研究者提供可靠數(shù)據(jù)支持。適用于線粒體功能研究、凋亡通路機(jī)制解析、疾病模型構(gòu)建等科研場景，尤其在探究腫瘤耐藥性、缺血再灌注損傷、阿爾茨海默病等相關(guān)蛋白表達(dá)變化時(shí)展現(xiàn)優(yōu)異性能。采用單克隆抗體技術(shù)確保批次間高度一致性，滿足多維度實(shí)驗(yàn)設(shè)計(jì)的重復(fù)性要求，為細(xì)胞生物學(xué)、分子病理學(xué)等基礎(chǔ)研究提供精準(zhǔn)工具。
Uniprot No.：

P99999
基因名：

CYCS
別名：

CYC antibody; CYC_HUMAN antibody; CYCS antibody; Cytochrome c antibody; Cytochrome c somatic antibody; HCS antibody; THC4 antibody
宿主：

Mouse
反應(yīng)種屬：

Human,Mouse,Rat
免疫原：

Recombinant Protein
免疫原種屬：

Human, Mouse, Rat
標(biāo)記方式：

Non-conjugated
抗體亞型：

IgG
克隆號：

7D8
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

PBS, pH 7.4, containing 0.5%BSA, 0.02% sodium azide as Preservative and 50% Glycerol.
產(chǎn)品提供形式：

Liquid
應(yīng)用范圍：

ELISA,WB,IHC

推薦稀釋比：

Application	Recommended Dilution
WB	1:500-1:5000
IHC	1:50-1:500

Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
Immunohistochemistry (IHC) Protocol
儲(chǔ)存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價(jià)

靶點(diǎn)詳情

功能：

Electron carrier protein. The oxidized form of the cytochrome c heme group can accept an electron from the heme group of the cytochrome c1 subunit of cytochrome reductase. Cytochrome c then transfers this electron to the cytochrome oxidase complex, the final protein carrier in the mitochondrial electron-transport chain.; Plays a role in apoptosis. Suppression of the anti-apoptotic members or activation of the pro-apoptotic members of the Bcl-2 family leads to altered mitochondrial membrane permeability resulting in release of cytochrome c into the cytosol. Binding of cytochrome c to Apaf-1 triggers the activation of caspase-9, which then accelerates apoptosis by activating other caspases.
基因功能參考文獻(xiàn)：
1. Cytochrome c was upregulated in the primary Sjogren's syndrome patients, indicating the potential role of cytochrome c in the pathogenesis and development of primary Sjogren's syndrome. PMID: 29257225
2. The caspase-8/Bid/cytochrome c axis links signals from death receptors to mitochondrial reactive oxygen species production. PMID: 28888620
3. This work reveals a direct conformational link between the 40-57 Omega-loop of cytochrome c in which residue 41 resides and the dynamical properties of the axial ligand to the heme iron. PMID: 27461282
4. The naturally occurring Y48H variant of cytochrome c in its oxidized heme state is more peroxidatic than either the Wild Type protein or the G41S variant that is also implicated in thrombocytopenia. PMID: 29083920
5. ROCK activation phosphorylated Rac1b at Ser71 and increased reactive oxygen species (ROS) levels by facilitating the interaction between Rac1b and cytochrome c. Conversely, ROCK inactivation abolished their interaction, concomitant with ROS reduction. PMID: 28317242
6. Data suggest that although HCCS mediates heme attachment to N-terminal cysteine in heme-attachment site (CXXXH) of cytochrome C variants, up to 50% of cytochrome C produced is modified in an oxygen-dependent manner, resulting in a mixed population of cytochrome c. [HCCS = holocytochrome c synthase] PMID: 28617588
7. Data suggest that the stronger effect of K72A mutation on the peroxidase activity of human versus yeast cytochrome c results from relief of steric interactions between side chains at positions 72 and 81 (Ile in human vs Ala in yeast), which suppresses the dynamics of omega-loop D necessary for the intrinsic peroxidase activity of cytochrome c. PMID: 28598148
8. These findings establish a framework for understanding the molecular basis of cytochrome c-mediated blocking of SET/TAF-Ibeta. PMID: 26216969
9. Monitoring of serum cytochrome c might also serve as a sensitive apoptotic marker in vivo reflecting chemotherapy-induced cell death burden in patients with non-small cell lung cancer. PMID: 25578497
10. G-Rh2 causes rapid and dramatic translocation of both Bak and Bax, which subsequently triggers mitochondrial cytochrome c release and consequent caspase activation. PMID: 23443079
11. The mitochondrial metalloprotease OMA1 was activated in a Bax- and Bak-dependent fashion. PMID: 25275009
12. In vitro ultrastructural changes of MCF-7 for metastasise bone cancer and induction of apoptosis via mitochondrial cytochrome C released by CaCO3/Dox nanocrystals PMID: 25028650
13. a mechanism of multiple radical formations in the cytochrome c-phospholipid complexes under H2O2 treatment, consistent with the stabilization of the radical in the G41S mutant, which elicits a greater peroxidase activity from cytochrome c PMID: 24099549
14. proposed that mutation of residue 41, and interaction with cardiolipin, increase peroxidase activity by altering the 40-57 Omega loop and its hydrogen bond network with the propionate of haem ring A; these changes enhance access of hydrogen peroxide and substrate to the haem PMID: 24329121
15. Data indicate a novel missense mutation (Y48H) of the cytochrome c (CYCS) gene responsible for thrombocytopenia. PMID: 24326104
16. results suggest the impact of residue 41 on the conformation of cytochrome c influences its ability to act in both of its physiological roles, electron transport and caspase activation PMID: 23334161
17. structural characterization of cytochrome c in micelle PMID: 23070294
18. Data indicate that the formation of cytochrome c-Apaf-1 apoptosome and the presence of Smac are absolutely required for PSAP-induced apoptosis. PMID: 23207240
19. Spectroscopic analyses of HCCS alone and complexes of HCCS with site-directed variants of cytochrome c revealed the fundamental steps of heme attachment and maturation. PMID: 23150584
20. The levels of cellular apoptosis-associated proteins such as Smac/DIABLO, Cyto C, and the activated fragment of caspase-3 increased in pancreatic cancer cells, but the expression of XIAP was significantly decreased after 24 h treatment with the combination of TRAIL and gemcitabine. PMID: 22320973
21. CCN1 promotes the activation of p53 and p38 MAPK, which mediate enhanced cytochrome c release to amplify the cytotoxicity of TNFalpha. PMID: 22363611
22. Translocation of ARTS initiates a first wave of caspase activation leading to the subsequent release of additional mitochondrial factors, including cytochrome C and SMAC/Diablo. PMID: 21869827
23. Tyrosine phosphorylation turns alkaline transition into a biologically relevant process and makes human cytochrome c behave as an anti-apoptotic switch. PMID: 21706253
24. mitochondrial import and direct electron transfer from cytochrome c to Rac1 modulates mitochondrial H(2)O(2) production in alveolar macrophages pulmonary fibrosis. PMID: 22157762
25. Dynamic changes in cytochrome c distribution at the Raman band of 750 cm(-1) were observed after adding an apoptosis inducer to the cells. PMID: 22184220
26. Specific nitration of tyrosines 46 and 48 makes cytochrome c assemble a non-functional apoptosome. PMID: 22192356
27. Studies indicate that the CYCS mutation in TP Cargeegis a glycine 41 replacement by serine, which yields a cytochrome C variant with enhanced apoptotic pathway activity in vitro. PMID: 22102269
28. Data show that G-Rh2 and Bet A cooperated to induce Bax traslocation to mitochondria and cytochrome c release, and enhanced cleavage of caspase-8 and Bid. PMID: 21751259
29. Cerebrospinal fluid Bcl-2 and cytochrome C levels are elevated in adults after severe traumatic brain injury. PMID: 21448217
30. Resveratrol induces p53-independent, X-linked inhibitor of apoptosis protein (XIAP)-mediated Bax protein oligomerization on mitochondria to initiate cytochrome c release and caspase activation. PMID: 21712378
31. heme electronic structure change may ultimately be responsible for the enhanced proapoptotic activity of G41S mutated human cyt c PMID: 21192676
32. it is the specific nitration of solvent-exposed Tyr74 which enhances the peroxidase activity and blocks the ability of cytochrome c to activate caspase-9, thereby preventing the apoptosis signaling pathway PMID: 20227384
33. Data show that sorafenib initiated lethal apoptotic process through the release of cytochrome c and caspase 3/7 activation. PMID: 19770576
34. Serum LRG when bound to extracellular Cyt c that is released from apoptotic cells acts as a survival factor for lymphocytes and possibly other cells that are susceptible to the toxic effect of extracellular Cyt c. PMID: 19851871
35. NOA36/ZNF330 is translocated from the mitochondria to the cytoplasm when apoptosis is induced and that it contributes to cytochrome c release. PMID: 19895853
36. Membrane-associated XIAP induces mitochondrial outer membrane permeabilization leading to cytochrome c and Smac release, which is dependent on Bax and Bak. PMID: 19875445
37. galectin-3 is enriched in the mitochondria and prevents mitochondrial damage and cytochrome c release PMID: 11839755
38. non-rare allelic variants of the Cyt c protein are absent in the populations analyzed in this study PMID: 16934433
39. Mutation of human cytochrome c enhances the intrinsic apoptotic pathway and causes thrombocytopenia PMID: 18345000
40. MICS1 individually functions in mitochondrial morphology and cytochrome c release. PMID: 18417609
41. Serum cyto-c is a potent tumor marker as a predictor for malignant potential in several different types of cancer. PMID: 18825408
42. Both neurons and cancer cells strictly inhibit cytochrome c-mediated apoptosis by a mechanism dependent on glucose metabolism. PMID: 19029908
43. In 77 Italian patients with inherited thrombocytopenia and clinical and laboratory features similar to those of patients with the CYCS missense (Gly41Ser) mutation, no alterations of the open reading frame were identified. PMID: 19172527
44. there was no evidence of somatic mutations of CYTOCHROME C in the cancers PMID: 19404857
45. No difference in the serum level of cytochrome c was seen among the the groups of patients with type 2 diabetes, controls or in subjects with IGT. PMID: 19640329
顯示更多

收起更多
相關(guān)疾病：

Thrombocytopenia 4 (THC4)
亞細(xì)胞定位：

Mitochondrion intermembrane space. Note=Loosely associated with the inner membrane.
蛋白家族：

Cytochrome c family
數(shù)據(jù)庫鏈接：

HGNC: 19986

OMIM: 123970

KEGG: hsa:54205

STRING: 9606.ENSP00000307786

UniGene: Hs.437060

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human